An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma

Background: Tumor mutational burden (TMB) was verified to be closely associated with immune checkpoint inhibitors, but it is unclear whether gene mutation has an effect on immunotherapy of hepatocellular carcinoma (HCC). This research aimed to investigate the underlying correlation between gene muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Zhuomao, Wang, Yongdan, Cao, Zhirui, Li, Pan, Zhang, Shijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304048/
https://www.ncbi.nlm.nih.gov/pubmed/32596147
http://dx.doi.org/10.3389/fonc.2020.00853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304048/
https://www.ncbi.nlm.nih.gov/pubmed/32596147
http://dx.doi.org/10.3389/fonc.2020.00853

Ejemplares similares